Package 47781-408-04

{"route": ["TRANSDERMAL"], "spl_id": "7f83c8aa-7590-e2fe-4998-55323eadd112", "openfda": {"nui": ["N0000175689", "N0000175685"], "unii": ["40D3SCR4GZ"], "rxcui": ["904870", "904876", "904880", "1432969"], "spl_set_id": ["315284b8-32ab-d34a-ea02-f501c6131bcc"], "pharm_class_epc": ["Partial Opioid Agonist [EPC]"], "pharm_class_moa": ["Partial Opioid Agonists [MoA]"], "manufacturer_name": ["Alvogen Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 POUCH in 1 CARTON (47781-408-04)  / 1 PATCH in 1 POUCH (47781-408-11)  / 168 h in 1 PATCH", "package_ndc": "47781-408-04", "marketing_end_date": "20270131", "marketing_start_date": "20220829"}], "brand_name": "buprenorphine transdermal system", "product_id": "47781-408_7f83c8aa-7590-e2fe-4998-55323eadd112", "dosage_form": "PATCH, EXTENDED RELEASE", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "47781-408", "dea_schedule": "CIII", "generic_name": "buprenorphine", "labeler_name": "Alvogen Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "buprenorphine transdermal system", "active_ingredients": [{"name": "BUPRENORPHINE", "strength": "20 ug/h"}], "application_number": "ANDA207490", "marketing_category": "ANDA", "marketing_end_date": "20270131", "marketing_start_date": "20220517"}